The Future of Pharma Data, AI, and Drug Development - with Glen de Vries of Medidata
07/14/20 • 25 min
1 Listener
Glen de Vries cofounded Medidata in 1999, offering SaaS-based clinical development solutions addressing the functioning of customers' clinical trials, and 20 years later the company - which he still leads - sold to Dassault Systemes for almost $6 billion. What a triumph, Glen! Thank you for joining the podcast. Listen in as Glen shares his unique and valuable perspective on the current state and potential futures for the data ecosystem in Life Sciences. Want to stay on the cutting edge of emerging data-driven technologies? Try out Emerj Plus: emerj.com/p1
Glen de Vries cofounded Medidata in 1999, offering SaaS-based clinical development solutions addressing the functioning of customers' clinical trials, and 20 years later the company - which he still leads - sold to Dassault Systemes for almost $6 billion. What a triumph, Glen! Thank you for joining the podcast. Listen in as Glen shares his unique and valuable perspective on the current state and potential futures for the data ecosystem in Life Sciences. Want to stay on the cutting edge of emerging data-driven technologies? Try out Emerj Plus: emerj.com/p1
Previous Episode
![undefined - [AI Futures] Formation of Ethically Aligned AI Standards - with Dr. Karachalios PhD, Managing Director of IEEE Standards (S1E3)](https://storage.googleapis.com/goodpods-images-bucket/episode_images/3d45fe8667a478574a514dab79818cbe616ccbc8e43b43d00dde0c2f1a20d25c.avif)
[AI Futures] Formation of Ethically Aligned AI Standards - with Dr. Karachalios PhD, Managing Director of IEEE Standards (S1E3)
Today's interview is with, Konstantinos Karachalios, Managing Director of the Institute of Electrical and Electronics Engineers Standards Association (ieee.org).
Konstantinos earned a Ph.D. in Energy Engineering (nuclear reactor safety) from the University of Stuttgart. Before IEEE, Konstantinos played a crucial role in international scenario simulation for large-scale nuclear reactor accidents. And with the European Patent Office, his experience included establishing EPO’s patent academy.
For 100+ years, the IEEE has developed global standards for bleeding-edge technologies like nuclear power, blockchain, nanotech, systems engineering, and many more. Emerj is a big supporter of the IEEE's AI standards for "Ethically Aligned Design", and in this talk, we speak about what's happening in the early stages of AI standards and policy formation around the world.
Next Episode
Tech Investments Post Covid - with Brett Beranek of Nuance
Today's discussion is with Brett Beranek of Nuance Communications, arguably the best-known NLP company in the world. Nuance has been selling AI to enterprises for decades, earning billions of revenue in this mature space. In this episode, Brett shares valuable insights and predictions about how technology priorities might and should transform in the post-Covid world. Learn more with Emerj's Pandemic Response - Business Continuity Playbook: emerj.com/p1
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/the-ai-in-business-podcast-22624/the-future-of-pharma-data-ai-and-drug-development-with-glen-de-vries-o-4933367"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to the future of pharma data, ai, and drug development - with glen de vries of medidata on goodpods" style="width: 225px" /> </a>
Copy